Comparative platelet activation profile between pooled granulocyte concentrates ( PGC ) versus apheresis ( APC ) and buffy coat ( BC ‐ PC ) method
Transfusion · 2026
DOI: 10.1111/trf.70098 ↗At a glance
Vergleichsstudie in Transfusion, 2026. Written by Fabrice Cognasse and 11 co-authors. Institution: EFS AURA, Etablissement Français du Sang Auvergne Rhône Alpes, Décines, France. Major MEDLINE topics: Granulocytes, Blood Buffy Coat, Platelet Activation, Blood Component Removal. Cited 1 times so far (Crossref); 30 references. Funded by: Etablissement Français du Sang, The Association "Les Amis de Rémi" Savigneux, Agence Nationale de la Recherche.
Abstract (original language)
Background
Granulocyte transfusion remains a therapeutic option for patients with severe neutropenia or granulocyte dysfunction, though its clinical benefit is still debated. Traditional pooled granulocyte concentrates (PGC) are produced by donor stimulation and apheresis, procedures that are costly and ethically restrictive. To overcome these limitations, PGC derived from buffy coat layers (BC) have emerged as a simpler and safer alternative, yet little is known about their platelet composition and activation profile. Study Design /Methods Whole blood donations ( n = 256) were processed into BC, pooled (20 BC per batch), and reconstituted to form PGC20 units. Hematologic parameters and platelet activation markers (CD41, CD62P, CD63) were analyzed by automated counting and flow cytometry and compared with standard apheresis (APC) and buffy coat–derived platelet concentrates (BC‐PC).
Results
PGC show a high platelet concentration comparable to BC‐PC, with an increased mean platelet volume. The elevated expression of CD62P and CD63 confirms marked platelet activation, while the slight decrease in CD41 suggests membrane alteration during processing, indicating a mixed platelet–granulocyte product with immunomodulatory potential that requires optimization for safe transfusional use.
Conclusions
PGC derived from buffy coat pools combines high granulocyte yield with an activated platelet population. This bioactive platelet component may enhance immune interactions but warrants further optimization to ensure transfusion safety and product standardization.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- EFS AURA, Etablissement Français du Sang Auvergne Rhône Alpes, Décines, France.
- INSERM, U 1059 SAINBIOSE, Université Jean Monnet, Mines Saint-Étienne, Saint-Étienne, France.
ORCID profiles: Anne-Claire Duchez
Funding
- Etablissement Français du Sang
- The Association "Les Amis de Rémi" Savigneux
- Agence Nationale de la Recherche
Cite
APA
Cognasse, F., Desseux, K., Artero, V., Duraffourg, V., Crespe, D., Eyraud, M. A., Arthaud, C. A., Prier, A., Maillot, V., Duchez, A. C., Chavarin, P., & Hamzeh-Cognasse, H. (2026). Comparative platelet activation profile between pooled granulocyte concentrates ( PGC ) versus apheresis ( APC ) and buffy coat ( BC ‐ PC ) method. Transfusion. https://doi.org/10.1111/trf.70098
Vancouver
Cognasse F, Desseux K, Artero V, Duraffourg V, Crespe D, Eyraud MA, et al. Comparative platelet activation profile between pooled granulocyte concentrates ( PGC ) versus apheresis ( APC ) and buffy coat ( BC ‐ PC ) method. Transfusion. 2026. doi:10.1111/trf.70098
BibTeX
@article{Cognasse2026,
author = {Cognasse, Fabrice and Desseux, Karine and Artero, Véronique and Duraffourg, Veronique and Crespe, Damien and Eyraud, Marie-Ange and Arthaud, Charles-Antoine and Prier, Amélie and Maillot, Victorine and Duchez, Anne-Claire and Chavarin, Patricia and Hamzeh-Cognasse, Hind},
title = {Comparative platelet activation profile between pooled granulocyte concentrates ( PGC ) versus apheresis ( APC ) and buffy coat ( BC ‐ PC ) method},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70098}
}
EUVIMED